Art

J-GLOBAL ID：201802220010341151   Reference number：18A1071336

A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients

ゴナドトロピン放出ホルモン拮抗薬は前立腺癌患者における血清副腎アンドロゲン濃度を低下させる【JST・京大機械翻訳】

Author (9)： Miyazawa Yoshiyuki (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Sekine Yoshitaka (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Syuto Takahiro (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Nomura Masashi (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Koike Hidekazu (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Matsui Hiroshi (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Shibata Yasuhiro (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Ito Kazuto (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Suzuki Kazuhiro (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan)
Material： BMC Urology (Web)
Volume： 17  Issue： 1  Page： 70  Publication year： 2017 
JST Material Number： U7453A  ISSN： 1471-2490  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Background Adrenal androgens p...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1071336&from=J-GLOBAL&jstjournalNo=U7453A") }}

Thesaurus term： LC-MS analysis ,  *male sex hormone ,  *Serum ,  therapy ,  *prostatic tumor ,  pretreatment ,  testis ,  luteinizing hormone ,  Castration ,  FSH ,  *adrenal gland ,  *Gonadotropin-Releasing Hormone ,  *patient ,  immunoassay ,  bioassay
Semi thesaurus term： immunoassay ,  *アンタゴニスト , 【Automatic Indexing@JST】

Author keywords (3)： Prostate cancer ,  GnRH antagonist ,  Adrenal androgen

JST classification (1)： Sex hormones  (EB08050O)

Reference (30)：

• Nat Rev Urol; Prostate cancer in Asian man; K Ito; 11; 2014; 197-212; 10.1038/nrurol.2014.42; CR1;
• J Natl Compr Cancer Netw; Prostate cancer, version 2.2014; JL Mohler, PW Kantoff, AJ Armstrong; 12; 2014; 686-718; 10.6004/jnccn.2014.0072; CR2;
• J Urol; A 1-year, open label, randomized phase II dose finding study of degarelix for the treatment of prostate cancer in North America; M Gittelman, P Pommerville, B Persson; 180; 2008; 1986-1992; 10.1016/j.juro.2008.07.033; CR3;
• Eur Urol; Disease control outcomes from analysis of pooled individual patient data from five comparative randomised clinical trials of degarelix versus luteinising hormone-releasing hormone agonists; L Klotz, K Miller, ED Crawford; 66; 2014; 1101-1108; 10.1016/j.eururo.2013.12.063; CR4;
• Eur Urol; Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blocker-results from a 1-yr, multicentre, randomised, phase 2 dosage-finding study in the treatment of prostate cancer; H Poppel, B Tombal, J Rosette; 54; 2008; 805-813; 10.1016/j.eururo.2008.04.065; CR5;

Terms in the title (7)： ゴナドトロピン放出ホルモン ,  拮抗薬 ,  前立腺 ,  癌患者 ,  血清 ,  副腎 ,  アンドロゲン